29 Mar 2017 08:38 CEST
CURETIS
Connect_20170329_curetis_pr__q2-17_conference_update_en_approved.pdf Connect_20170329_curetis_pr__q2-17_conference_update_de_approved.pdf
Euronext
NL0011509294
CURE